wp-content/
17 pages · Updated July 26, 2026
Pages
- Privacy Statement
- Evommune_GUF_2024_EVO756-HV001_Oral_Presentation_22Nov2024_2
- evommune_ahs_presentation_role_of_mrgprx2_in_migraine-pdf.html
- 2026 SID EVO301 poster FINAL
- Slide 1
- In vitro and in vivo efficacy of selective small-molecule PKC-theta inhibitors
- Slide 1
- Slide 1
- Slide 1
- Slide 1
- Transcriptional profiling of primary human-skin derived mast cell activation by various MRGPRX2 agonists and inhibition with EVO756
- Slide 1
- evo756_poster_pr-pdf.html
- PowerPoint Presentation
- Evommune Announces Strategic Collaboration with Maruho to Develop and Commercialize MRGPRX2 antagonist EVO756 in Japan
- 16_Evommune_Accutar_Biotechnology_Announce_AI Drug_Discovery_Collaboration_(003)_112823
- Slide 1